Eveline A M Heijnsdijk (E A M Heijnsdijk, Eveline Am Heijnsdijk)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Magnetic Resonance Imaging

Radical Prostatectomy

Top Venues

International journal of cancer

Cancer medicine

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenwei Yang, Eveline A M Heijnsdijk, Lisa F Newcomb, Dimitris Rizopoulos, Nicole S Erler
Exploring the relation of active surveillance schedules and prostate cancer mortality. Cancer medicine 13 (5) (2024)
Zhenwei Yang, Eveline A M Heijnsdijk, Lisa F Newcomb, Dimitris Rizopoulos, Nicole S Erler
Exploring the relation of active surveillance schedules and prostate cancer mortality. Cancer medicine 13 (5) (2024)
Lindy M Kregting, Nicolien T van Ravesteyn, Sarocha Chootipongchaivat, Eveline A M Heijnsdijk, Johannes D M Otten, Mireille J M Broeders, Harry de Koning
Cumulative risks of false positive recall and screen-detected breast cancer after multiple screening examinations. International journal of cancer (2023)
Lindy M Kregting, Valérie D V Sankatsing, Eveline A M Heijnsdijk, Harry de Koning, Nicolien T van Ravesteyn
Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modelled strategies. International journal of cancer 151 (2) (2022)
Lindy M Kregting, Valérie D V Sankatsing, Eveline A M Heijnsdijk, Harry de Koning, Nicolien T van Ravesteyn
Reply to: Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies". International journal of cancer 151 (4) (2022)
Yaw A Nyame, Roman Gulati, Eveline A M Heijnsdijk, Alex Tsodikov, Angela B Smith, John L Gore, Ruth B Etzioni
The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis. Journal of the National Cancer Institute 113 (10) (2022)
Eveline A M Heijnsdijk, Steven J Supit, Leendert H J Looijenga, Harry de Koning
Screening for cancers with a good prognosis: The case of testicular germ cell cancer. Cancer medicine 10 (8) (2021)
Abraham M Getaneh, Eveline A M Heijnsdijk, Harry de Koning
Cost-effectiveness of multiparametric magnetic resonance imaging and MRI-guided biopsy in a population-based prostate cancer screening setting using a micro-simulation model. Cancer medicine 10 (12) (2021)
Abraham M Getaneh, Eveline A M Heijnsdijk, Monique J Roobol, Harry de Koning
Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios. Cancer medicine 9 (20) (2020)
Nadine Zielonke, Lindy M Kregting, Eveline A M Heijnsdijk, Piret Veerus, Sirpa Heinävaara, Martin McKee, Inge M C M de Kok, Harry de Koning, Nicolien T van Ravesteyn, null null
The potential of breast cancer screening in Europe. International journal of cancer 148 (2) (2020)
Valérie D V Sankatsing, Nicolien T van Ravesteyn, Eveline A M Heijnsdijk, Mireille J M Broeders, Harry de Koning
Risk stratification in breast cancer screening: Cost-effectiveness and harm-benefit ratios for low-risk and high-risk women. International journal of cancer 147 (11) (2020)
Eveline A M Heijnsdijk, Marcell Csanádi, Andrea Gini, Kevin Ten Haaf, Rita Bendes, Ahti Anttila, Carlo Senore, Harry de Koning
All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: A review and modeling study. Cancer medicine 8 (13) (2019)
Eveline A M Heijnsdijk, Daan Nieboer, Tullika Garg, Iris Lansdorp-Vogelaar, Harry J de Koning, Matthew E Nielsen
Cost-effectiveness of surveillance schedules in older adults with non-muscle-invasive bladder cancer. BJU international 123 (2) (2018)
Eveline A M Heijnsdijk, Chris H Bangma, Josep M Borràs, Tiago M de Carvalho, Xavier Castells, Martin Eklund, Josep A Espinàs, Markus Graefen, Henrik Grönberg, Iris Lansdorp-Vogelaar, Pim J van Leeuwen, Vera Nelen, Franz Recker, Monique J Roobol, Pieter Vandenbulcke, Harry J de Koning
Summary statement on screening for prostate cancer in Europe. International journal of cancer 142 (4) (2017)
Valérie D V Sankatsing, N T van Ravesteyn, Eveline A M Heijnsdijk, H J de Koning
Authors' reply to: "Questionable method for estimating the influence of mammography screening on breast cancer mortality in the Netherlands". International journal of cancer 141 (8) (2017)
Tiago M de Carvalho, Eveline A M Heijnsdijk, Harry J de Koning
Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance. Cancer 124 (3) (2017)
Harry J de Koning, Roman Gulati, Sue M Moss, Jonas Hugosson, Paul F Pinsky, Christine D Berg, Anssi Auvinen, Gerald L Andriole, Monique J Roobol, E David Crawford, Vera Nelen, Maciej Kwiatkowski, Marco Zappa, Marcos Luján, Arnauld Villers, Tiago M de Carvalho, Eric J Feuer, Alex Tsodikov, Angela B Mariotto, Eveline A M Heijnsdijk, Ruth Etzioni
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials. Cancer 124 (6) (2017)